Map to Our Locations

Research

Research 700px

West Coast retina Consultants is actively involved in clinical research, either investigator initiated academic studies or industry sponsored clinical trials. We understand that research is very important in discovering new treatments, improving standard of care and opening new opportunities for patients and medical community. We actively collaborate with other retina specialists, geneticists and ophthalmologists from UBC/VGH Eye Care Centre.


Our research team:

  • Dr David Albiani
  • Dr Andrew Merkur
  • Dr Andrew Kirker
  • Dr Farzin Forooghian
  • Aleksandra Kuzmanovic, MSc CCRP- Research Coordinator
  • Garnet Elvena, Eiko Kato, Katarina Mendoza- BCVA examiners.

List of current studies:

  • HAWK: A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration
  • SAPPHIRE: A randomized, masked, controlled trial to study the safety and efficacy of suprachoroidal CLS TA in conjunction with intravitreal aflibercept in subjects with retinal vein occlusion (Protocol number: CLS1003 301)
  • CHROMA:A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration (Protocol GX29176) 
  • INVESTIGATOR INITIATED STUDIES:Comparison of Pain with 5% Povidone-Iodine Verses 0.1% Chlorhexidine Antiseptic for Intravitreal Injection
  • DRCR STUDIES:
    • Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk (PROTOCOL W)
    • Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity (PROTOCOL V)
    • Peripheral Diabetic Retinopathy (DR)Lesions on Ultrawide-field Fundus Images and Risk of DR Worsening Over Time  (PROTOCOL AA)
 

If you need more information about research at WCRC or would like to participate in some of the studies, please contact Aleksandra Kuzmanovic at 604-875-4253 or by e-mail This email address is being protected from spambots. You need JavaScript enabled to view it.